PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.

Fiche publication

Date publication

mars 2024

Journal

Cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CHAIGNEAU Loïc , Pr KURTZ Jean-Emmanuel , Pr MALOUF Gabriel , Dr HERVIEU Alice , Dr CHARON-BARRA Céline , Dr GANTZER Justine

Tous les auteurs :
Gantzer J, Toulmonde M, Severac F, Chamseddine AN, Charon-Barra C, Vinson C, Hervieu A, Bourgmayer A, Bertucci F, Ryckewaert T, Valentin T, Firmin N, Chaigneau L, Bompas E, Follana P, Rioux-Leclercq N, Soibinet-Oudot P, Bozec L, Le Loarer F, Weingertner N, Chevreau C, Duffaud F, Blay JY, Kurtz JE, Schöffski P, Brahmi M, Malouf GG

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38470379

Résumé

Perivascular epithelioid cell neoplasms (PEComas) encompass a heterogeneous family of mesenchymal tumors. Previously described clinicopathologic features aimed at distinguishing benign from malignant variants but lacked prognostic value.